STOCK TITAN

Mobia Medical, Inc. (MOBI) grants new stock option awards to director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Mobia Medical, Inc. director Reza Zadno received two stock option awards covering 16,260 and 19,150 shares of common stock at an exercise price of $11.57 per share, expiring on July 14, 2036. Vesting schedules include three substantially equal annual installments and full vesting at the 2027 Annual Meeting.

Positive

  • None.

Negative

  • None.
Insider Zadno Reza
Role Director
Type Security Shares Price Value
Grant/Award Stock Option F1 19,150 $0.00 $0.00
Grant/Award Stock Option F2 16,260 $0.00 $0.00
Holdings After Transaction: Stock Option — 35,410 shares (Direct)
Footnotes (2)
  1. F1. The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.
  2. F2. The stock option will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.
Stock options granted 16,260 options Director award dated 2026-07-14
Stock options granted 19,150 options Second director award dated 2026-07-14
Exercise price $11.57 per share Conversion or exercise price for both option grants
Expiration date 2036-07-14 Expiration for both stock option awards
Stock Option financial
"The stock option will vest in three substantially equal installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Non-Employee Director Compensation Policy financial
"consistent with the Non-Employee Director Compensation Policy."
substantially equal installments financial
"will vest in three substantially equal installments on the first three anniversaries"
Annual Meeting financial
"will fully vest at the 2027 Annual Meeting, consistent with"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Mobia Medical (MOBI) director Reza Zadno receive in this Form 4 filing?

Director Reza Zadno received two stock option grants covering 16,260 and 19,150 underlying shares of Mobia Medical common stock. Both options were granted on July 14, 2026 as part of his non-employee director compensation.

What is the exercise price of the stock options granted to Reza Zadno at Mobia Medical (MOBI)?

Both option awards carry an exercise price of $11.57 per share. This means Zadno can purchase Mobia Medical common stock at $11.57 per share upon exercise of the options, subject to the applicable vesting schedules and expiration date.

When do Reza Zadno’s Mobia Medical (MOBI) stock options expire?

Each of the stock option grants to Reza Zadno expires on July 14, 2036. After this expiration date, any unexercised portion of these options will lapse and can no longer be used to acquire Mobia Medical common shares.

How do the stock options granted to Reza Zadno at Mobia Medical (MOBI) vest?

The filing notes two vesting structures: one stock option vests in three substantially equal installments on the first three anniversaries of the grant date, while another will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.

Are Reza Zadno’s Mobia Medical (MOBI) option grants open-market purchases or compensation awards?

These transactions are coded as “A” grants/awards, indicating compensation-related stock option awards rather than open-market purchases or sales. The options were granted at $11.57 per share with specified vesting and a July 14, 2036 expiration.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zadno Reza

(Last)(First)(Middle)
2802 FLINTROCK TRACE, SUITE 226

(Street)
AUSTIN TEXAS 78738

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Mobia Medical, Inc. [ MOBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$11.5707/14/2026A19,150 (1)07/14/2036Common Stock19,150$019,150D
Stock Option$11.5707/14/2026A16,260 (2)07/14/2036Common Stock16,260$016,260D
Explanation of Responses:
1. The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.
2. The stock option will fully vest at the 2027 Annual Meeting, consistent with the Non-Employee Director Compensation Policy.
/s/ Chase Leavitt, Attorney-in-Fact07/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)